Neutropenia occurrence and predictors of reduced chemotherapy delivery: results
from the INC-EU prospective observational European neutropenia study.
Ruth Pettengell, Matthias Schwenkglenks, Robert Leonard, André Bosly, Robert Paridaens,
Manuel Constenla, Thomas D. Szucs and Christian Jackisch. Support. Care Cancer. 2008; 16(11):1299-309. Open access

A prospective multivariate analysis of risk factors associated with occurrence of
febrile neutropenia in any cycle in NHL patients receiving chemotherapy.
Ruth Pettengell, André Bosly, Thomas D. Szucs, Christian Jackisch, Robert Leonard, Robert
Paridaens, Manuel Constenla and Matthias Schwenkglenks. Blood 2007; 110(11): Abstract 4447.

Risk factors associated with occurrence of febrile neutropenia in NHL patients in
the first cycle of chemotherapy - A prospective multivariate model.
Ruth Pettengell, André Bosly, Thomas D. Szucs, Christian Jackisch, Robert Leonard, Robert
Paridaens, Manuel Constenla and Matthias Schwenkglenks. Blood 2007; 110(11): Abstract 1372.